Outsourcing-pharma1d
AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
Outsourcing-pharma1d
Eli Lilly invests $3bn in injectable drug manufacturing facility
Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
Outsourcing-pharma6d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Outsourcing-pharma6d
Top 5 radiopharmaceuticals startups with VC backing
Radiopharmaceuticals have also been the target of large partnership deals, including a recent $140 million partnership ...
Outsourcing-pharma8d
Novocure reports positive phase 3 results for tumor treating fields therapy
Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
Outsourcing-pharma8d
Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox
Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...
Outsourcing-pharma8d
PTC Therapeutics boosted by Novartis rights deal for Huntington’s program
The potential $2.9 billion deal stands the New Jersey company in good stead after recent disappointing results in its ALS ...